SEC filingsOct 12, 2026 to Oct 19, 2026: insiders reported 840 purchases and sales across 212 companies.840 insider purchases and sales in 7 daysSee the filings →
HornScout

Company profile

BRTX

Biorestorative Therapies Inc.
NASDAQHealth Care

Latest close: 1.54 USD · Oct 16, 2026 · 1 year · split-adjusted

On the price, the facts of the public record◆Adverse 8-K filing●Results filed
With an account, also○dividends▲splits◌next earningswith an account

End-of-day prices provided by Twelve Data · One close per session; the series does not update during the trading day.

Latest on record

The most recent facts, as filed.

Up to three of the most recent, checkable facts already loaded on this page, each linked to its source.

  1. Oct 9, 2026Material event · 8-KFiled by the company itself.Open the filing ↗
  2. Sep 11, 2026Material event · 8-KFiled by the company itself.Open the filing ↗
  3. Sep 10, 2026Material event · 8-KFiled by the company itself.Open the filing ↗

In numbers

What this profile holds, counted.

Closes · 1 year250
SEC filings on record70719 flagged findings
Reported transactions (Form 4)62since Jan 9, 2023
Corporate events (8-K)30since Nov 8, 2021

What the record says

Description, identity and filings, each with its source.

Every block cites its source. The colour of a finding marks its category — which document, who filed it — not how much it matters.

SEC topics

Regulatory history

Topics detected in its SEC reports, with the original excerpt.

Each topic is assigned by a classifier over the full filing; the excerpts show where it was detected and are not always enough to verify it. Open the filing to read it in full.

  • 2026-09-02reverse splitfreshOpen filing ↗
    “…pursuant to Section 13(a) of the Exchange Act. ☐ Item 3.03. Material Modification to Rights of Security Holders. On September 2,…”
    +1 more passage from the same document
    • “…the Exchange Act. ☐ Item 3.03. Material Modification to Rights of Security Holders. On September 2, 2026, BioRestorative Therapies,…”
  • 2026-08-25listing compliance noticefreshOpen filing ↗
    “…the Securities Exchange Act of 1934 (§240.12b-2 of this chapter). Emerging growth company ☐ If an emerging growth company, indicate…”
    +1 more passage from the same document
    • “…of this chapter). Emerging growth company ☐ If an emerging growth company, indicate by check mark if the registrant has elected…”

Original excerpts from SEC filings, untranslated. Not advice and not a prediction.

Listing notice in force

The exchange has notified the company that it fails a continued-listing requirement (8-K, item 3.01 of Aug 25, 2026).

Open the 8-K at the SEC

Reverse splits in 5 years

2 reverse splits in 5 years (1:4000 on Oct 27, 2021, 1:20 on Sep 8, 2026) · 1:80000 cumulative

The other times: of 247 securities that repeated a reverse split in 5 years, a year later the median was worth 0.10× the price on the day of the split; 189 lost more than half and 21 rose (243 with a price a year later).

Our own series, not the whole market: based on the splits we have on record (provider and SEC); an unrecorded one does not count. Historical distribution, not a prediction.

SEC record

SEC dossier

What this company has filed with the SEC, in plain language.

The 25 most recent filings (of 707)

Everything filed

Every SEC filing, newest first, with what it is. Below, each type with its own explanation.

  • Oct 9, 268-K ↗Current report · A senior executive left or was appointed
  • Sep 11, 268-K ↗Current report · A senior executive left or was appointed
  • Sep 10, 268-K/A ↗Current report · Auditor change filing (8-K Item 4.01) · amendment
  • Sep 2, 268-K ↗Current report · Change in shareholder rights · Bylaws or fiscal year change · Communication to the market
  • Sep 2, 268-K ↗Current report · Auditor change filing (8-K Item 4.01)
  • Aug 25, 268-K ↗Current report · Listing notice (8-K 3.01)
  • Aug 14, 26NT 10-Q ↗Late filing notice
  • Aug 14, 268-K ↗Current report · Other events
  • Aug 3, 26SCHEDULE 13G/A ↗Passive stake · Alta Partners LLC · 4.9% · event on Feb 13, 26 · amendment
  • Insider transaction · 2 Form 3 filingsshow all 2hide
  • Jul 16, 268-K ↗Current report · A senior executive left or was appointed
  • Insider transaction · 3 Form 3 filingsshow all 3hide
  • Jun 12, 268-K ↗Current report · A senior executive left or was appointed
  • Jun 12, 268-K ↗Current report · Entered a material agreement
  • May 29, 268-K ↗Current report · A senior executive left or was appointed
  • May 15, 26SCHEDULE 13G/A ↗Passive stake · Auctus Fund, LLC · 9.9% · event on Mar 31, 26 · amendment
  • May 14, 2610-Q ↗Quarterly report
  • May 1, 268-K ↗Current report · A senior executive left or was appointed
  • Apr 30, 26424B3 ↗Securities offering
  • Apr 27, 26POS AM ↗Securities offering
  • Apr 23, 268-K ↗Current report · Communication to the market
  • Apr 20, 26POS AM ↗Securities offering

707 filings on record, the oldest from Jun 6, 11.

Listing the 25 most recent filings of the 707 on record.

8-Ks, explained

Stress10Structure119Governance40
  • Oct 9, 26GovernanceA senior executive left or was appointed+1 more in the same filing8-K 5.02 ↗
  • Sep 11, 26GovernanceA senior executive left or was appointed+1 more in the same filing8-K 5.02 ↗
  • Sep 10, 26GovernanceAuditor change filing (8-K Item 4.01)+2 more in the same filing8-K/A 4.01 ↗
  • Sep 2, 26GovernanceAuditor change filing (8-K Item 4.01)+2 more in the same filing8-K 4.01 ↗
  • Aug 25, 26StressListing notice (8-K 3.01)+1 more in the same filing · nominal item 3.01: the filing covers another matter8-K 3.01 ↗
  • Jul 16, 26GovernanceA senior executive left or was appointed+1 more in the same filing8-K 5.02 ↗
  • Jun 12, 26GovernanceA senior executive left or was appointed+1 more in the same filing8-K 5.02 ↗
  • Jun 12, 26StructureEntered a material agreement+2 more in the same filing8-K 1.01 ↗
  • May 29, 26GovernanceA senior executive left or was appointed+2 more in the same filing8-K 5.02 ↗
  • May 1, 26GovernanceA senior executive left or was appointed8-K 5.02 ↗
  • Feb 17, 26StructureEntered a material agreement+2 more in the same filing8-K 1.01 ↗
  • Oct 8, 25StructureSold unregistered shares+3 more in the same filing8-K 3.02 ↗

11 older filings not shown · The record reaches back to Aug 26, 11.

Notable in the record

Stress disclosures older than the timeline above. They are individual events from the record, not a complete timeline: there may be more between them.

  • May 24, 24StressListing notice (8-K 3.01)8-K 3.01 ↗
  • May 24, 24StressPast accounts declared unreliable and being restated8-K 4.02 ↗
  • Nov 20, 20StressBankruptcy or receivership proceedings+5 more in the same filing8-K 1.03 ↗
  • Nov 5, 20StressBankruptcy or receivership proceedings+1 more in the same filing8-K 1.03 ↗
  • Apr 28, 20StressBankruptcy or receivership proceedings+2 more in the same filing8-K 1.03 ↗
  • Apr 3, 20StressBankruptcy or receivership proceedings+2 more in the same filing8-K 1.03 ↗
  • Mar 20, 20StressA debt obligation was accelerated+5 more in the same filing8-K 2.04 ↗
  • Feb 11, 20StressA debt obligation was accelerated+3 more in the same filing8-K 2.04 ↗

The full record holds 10 stress filings.

Corporate events are tracked from 2004-08-23, when the SEC renumbered 8-K items. Earlier filings use an incompatible numbering and are not classified here.

Ownership and control

Schedule 13D: stake and stated purpose

Filed by holders above 5% of a share class who cannot use the short form. It includes the investor's stated purpose: read it before assuming they seek influence.

Schedule 13G: short-form filing

The short form, for holders who meet specific requirements: institutional investors, passive investors without a control purpose, or exempt investors. Asset managers and index funds usually file it.

  • Auctus Fund, LLC9.9%Mar 31, 26SCHEDULE 13G/A ↗4 co-filers on this document — the figure is the largest single stake, not their sum. · 2 earlier filings
  • Auctus Fund Management LLC9.9%Mar 31, 25SCHEDULE 13G/A ↗4 co-filers on this document — the figure is the largest single stake, not their sum. · 1 earlier filing
  • Alta Partners LLC7.7%Feb 13, 26SCHEDULE 13G ↗1 earlier filing
  • Morrison Todd Hale7.7%Dec 18, 25SCHEDULE 13G/A ↗1 earlier filing
  • Mitchell P. Kopin4.1%Feb 11, 26SCHEDULE 13G ↗3 co-filers on this document — the figure is the largest single stake, not their sum.

Structured 13D/G data starts 2023-12, when the SEC moved these filings to a machine-readable format. Earlier filings exist but are not parsed here.

SEC record

Insider transactions

Buys and sells reported by officers, directors and major shareholders on SEC Form 4.

Buys and sells

  • Oct 28, 24Sell$2KDale Broadrick↗
  • Apr 9, 24Buy$8KFrancisco SilvaVP of Research and Development↗
  • Apr 8, 24Buy$538Francisco SilvaVP of Research and Development↗
  • Apr 8, 24Buy$1KFrancisco SilvaVP of Research and Development↗
  • Feb 9, 24Buy$114KDale Broadrick↗
  • Feb 8, 24Buy$112KDale Broadrick↗
  • Feb 8, 24Buy$92KDale Broadrick↗
  • Feb 7, 24Buy$50KDale Broadrick↗
  • Dec 1, 23Sell$469Dale Broadrick↗
  • Nov 27, 23Sell$525Dale Broadrick↗
  • Sep 15, 23Buy$4KLANCE ALSTODTPresident, CEO, COB↗
  • Sep 15, 23Buy$17KDale Broadrick↗

There are 20 more transactions in this stretch.

Stock compensation, tax and giftsshow the 8 other transactionshide

Stock compensation, tax withholding, option exercises and gifts. They are listed separately and are not included in the purchase and sale totals. The type describes the transaction, not the filer's intent.

  • Oct 6, 25Compensation$25KLANCE ALSTODTPresident, CEO, COB↗
  • Oct 6, 25Compensation$19KFrancisco SilvaVP of Research and Development↗
  • Mar 18, 24Tax$25KLANCE ALSTODTPresident, CEO, COB↗
  • Mar 18, 24Tax$24KFrancisco SilvaVP of Research and Development↗
  • Mar 20, 23Tax$20KLANCE ALSTODTPresident, CEO, COB↗
  • Mar 20, 23Tax$20KFrancisco SilvaVP of Research and Development↗
  • Feb 18, 23Tax$1KLANCE ALSTODTPresident, CEO, COB↗
  • Feb 18, 23Tax$1KFrancisco SilvaVP of Research and Development↗

The full record holds 42 transactions and goes back to Nov 30, 22.

Its sector and its market

Biorestorative Therapies Inc. among Health Care companies

The profile shows what is on record. Context and Radar place the company among those of its sector and region.

With an account you also get

  • The four engines — growth, trend, risk and context — each with its word and its score.
  • The risk band and the sector phase.
  • The company's fundamentals and accounts.
  • Watchlist: your list of companies, with the «since you follow it» figure.

The research continues

The profile tells the story. The market sets the scene.

From Biorestorative Therapies Inc., the path continues in the other areas. Each one is shown with its own example, named in its step.

  1. Place it in its market

    Seven layers of its region's market — rates, credit, stress, liquidity, regime, breadth and sectors — with historical precedents. Public example: Apple and ASML.

    See how Context works →
  2. See what deserves a closer look

    Every morning Radar screens the covered companies through a lens and explains why each candidate made the list. Public example: the lists from Aug 11, 2026.

    See how Radar works →
  3. Keep the why

    Follow Biorestorative Therapies Inc. in the Watchlist and review what changed since you added it: context, notices and filings. Written theses are coming soon. Public example: Apple.

    See an example review →

Coverage

What sits behind this page.

Where each figure comes from and how far it reaches.

Prices
End-of-day closes provided by Twelve Data. One close per session; not real time. Closes adjusted for splits.
Series quality
Series with incidents in the period; the chart shows what could be kept.
SEC records
707 documents on file, from Jun 6, 2011 to Oct 9, 2026.
Company description
No description available.
This page
Generated on Oct 19, 2026; refreshed through the day.

Start at your own pace

Explore first. Go deeper with access.

Every company's public profile is open. The full reading — context, Radar, watchlist — is inside, in an invitation-only beta.

Compare plans →
  • No account

    This profile for every company we cover: closing prices with the record's facts on the curve, the SEC file in plain language, insider trades included, and links to its sector and exchange.

  • Pro

    What matters today, with its reason, is free with an account. Pro adds, in the profile, each company's notices and their explanation and the analysis of its insiders; in Radar, all the lenses, which notice each candidate carries, filters by notice type and «no dilution», and the cycle cohort filter; and in Watchlist, more companies and notice changes with their reason.

  • Pro+

    Adds the Lab: test a hypothesis on comparable cohorts before reusing it; and bring your lenses to Radar.

Are the prices real time?

No. It is one close per session, from the provider and with the date shown on the profile; it does not update during the trading day.

Which SEC documents appear here?

Those filed with the SEC by the company, its insiders and its major shareholders, within our coverage: periodic reports (10-K, 10-Q, 20-F), material events (8-K), proposed sale notices (Form 144), insider transactions (Form 4) and stakes above 5% (13D/13G). Each links to the original on EDGAR.

Why does a European company show no SEC records?

It depends on the company: some European issuers file a 20-F or 6-K with the SEC and others don't. The profile shows whatever is on record; when there is nothing, it says so rather than guessing why. Europe does not yet have a common filing archive like EDGAR in the United States. The EU will open its own, ESAP, in July 2027 (managers' transactions arrive in January 2028), and we plan to add it once it is available.

Before forming a view on a company,
read what is on record.

One close per session. The record in plain language. Its sector and its market one link away. Your judgment when deciding.

Access by invitation while the beta lasts. Not advice: the profile shows what is on record; it does not recommend.